Abstract
Tendon injuries are common disorders that can significantly impact people’s lives. Unfortunately, the limited regenerative ability of tendons results in tissue healing in a scar-mediated manner. The current therapeutic strategies fail to fully recover the functions of the injured tendons, and as such, the conception of ‘scarless healing’ has gained prominent attention in the field of regenerative medicine. Interestingly, injured fetal tendons possess the capability to heal through regeneration, which builds an ideal blueprint for adult tendon regeneration. Studies have shown that fetal biochemical cues have the potential to improve adult tendon healing. Here we review the biological factors that contribute to fetal tendon regeneration and how manipulation of these biochemical cues in the adult tendon healing process could achieve regeneration.
Plain language summary
We reviewed the biological factors that contribute to fetal tendon regeneration and how manipulation of these biochemical cues in the adult tendon healing process could achieve regeneration. The results showed that inflammation and TGF-β level are the main elements involved in fetal tendon regeneration. Experimental manipulation of these biochemical cues in the adult tendon healing process demonstrated that although the blockade of TGF-β1, TGF-β2 and inflammation reduced scar tissue in adult tendon healing, this inhibition also destroyed the mechanical properties of the tendons. An effective alternative is regulating the specific downstream profibrotic effectors of both TGF-β1 and inflammation, which is preferable to those that completely inhibit these factors. Finally, TGF-β3 is a master regulator allowing a shift from adult scar healing to scarless healing, and the administration of TGF-β3 is a viable strategy to promote adult regenerative healing. In terms of mechanisms, TGF-β3 can activate Smad7 and inhibit the JNK/c-Jun signaling pathway to promote tendon regenerative healing.
References
- 1. . Tendon healing and platelet-rich plasma therapies. Expert Opin. Biol. Ther. 10(10), 1415–1426 (2010).
- 2. . The epidemiology of musculoskeletal tendinous and ligamentous injuries. Injury 39(12), 1338–1344 (2008).
- 3. . Tendon injury and tendinopathy: healing and repair. J. Bone Joint Surg. Am. 87(1), 187–202 (2005).
- 4. . Tendon healing: repair and regeneration. Annu. Rev. Biomed. Eng. 14, 47–71 (2012).
- 5. . The future: rehabilitation, gene therapy, optimization of healing. Foot Ankle Clin. 10(2), 383–397 (2005).
- 6. External stimulation: a potential therapeutic strategy for tendon–bone healing. Front. Bioeng. Biotechnol. 11, 1150290 (2023).
- 7. . Biology and augmentation of tendon-bone insertion repair. J. Orthop. Surg. Res. 5, 59 (2010).
- 8. . Flexor tendon: development, healing, adhesion formation, and contributing growth factors. Plast. Reconstr. Surg. 144(4), 639e–647e (2019).
- 9. . Flexor tendon injuries. J. Am. Acad. Orthop. Surg. 26(2), e26–e35 (2018).
- 10. . Biologics for tendon repair. Adv. Drug Deliv. Rev. 84 222–239 (2015).
- 11. . Extracorporeal shockwave therapy: a review. Sports Med. 32(13), 851–865 (2002).
- 12. Indirect co-culture with tendons or tenocytes can program amniotic epithelial cells towards stepwise tenogenic differentiation. PLoS ONE 7(2), e30974 (2012).
- 13. . Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359(1445), 839–850 (2004).
- 14. . Spontaneous repair of superficial defects in articular cartilage in a fetal lamb model. J. Bone Joint Surg. Am. 80(1), 4–10 (1998).
- 15. . Fetal tibial bone healing in utero: the effects of miniplate fixation. Plast. Reconstr. Surg. 92(5), 874–883 (1993).
- 16. . Wound healing in a fetal, adult, and scar tissue model: a comparative study. Wound Repair Regen. 18(3), 291–301 (2010).
- 17. . Regenerative versus reparative healing in tendon: a study of biomechanical and histological properties in fetal sheep. Ann. Biomed. Eng. 31(10), 1143–1152 (2003).
- 18. Regenerative properties of fetal sheep tendon are not adversely affected by transplantation into an adult environment. J. Orthop. Res. 24(11), 2124–2132 (2006).
- 19. . Fetal tendon healing: development of an experimental model. Plast. Reconstr. Surg. 92(6), 1155–1160; discussion 1161 (1993).
- 20. . The in vivo response of foetal tendons to sutures. J. Hand Surg. 20(3), 314–318 (1995).
- 21. Molecular mechanisms of fetal tendon regeneration versus adult fibrous repair. Int. J. Mol. Sci. 22(11), 5619 (2021).
- 22. . Tendon regeneration and scar formation: the concept of scarless healing. J. Orthop. Res. 33(6), 823–831 (2015).
- 23. . Embryonic wound healing: a primer for engineering novel therapies for tissue repair. Birth Defects Res. C Embryo Today 96(3), 258–270 (2012).
- 24. . Metabolic regulation of tendon inflammation and healing following injury. Curr. Rheumatol. Rep. 23(3), 15 (2021).
- 25. Inflammation activation and resolution in human tendon disease. Sci. Transl. Med. 7(311), 311ra173 (2015).
- 26. . Transient neutropenia increases macrophage accumulation and cell proliferation but does not improve repair following intratendinous rupture of Achilles tendon. J. Orthop. Res. 28(8), 1084–1091 (2010).
- 27. . Characterization of scar tissue biomechanics during adult murine flexor tendon healing. J. Mech. Behav. Biomed. Mater. 130, 105192 (2022).
- 28. . The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13 (2014).
- 29. . Tendon healing: an overview of physiology, biology, and pathology of tendon healing and systematic review of state of the art in tendon bioengineering. Knee Surg. Sports Traumatol. Arthrosc. 23(7), 2097–2105 (2015).
- 30. . Promoting effective tendon healing and remodeling. J. Orthop. Res. 36(12), 3115–3124 (2018).
- 31. . Tendon healing: can it be optimised? Br. J. Sports Med. 36(5), 315–316 (2002).
- 32. . Oxygen free radicals and tendon healing. J. Shoulder Elbow Surg. 16(Suppl. 5), S208–S214 (2007).
- 33. . The cellular basis of fibrotic tendon healing: challenges and opportunities. Transl. Res. 209, 156–168 (2019).
- 34. . Organ repair and regeneration: an overview. Birth Defects Res. C Embryo Today 96(1), 1–29 (2012).
- 35. . Establishing in vivo and ex vivo chick embryo models to investigate fetal tendon healing. Sci. Rep. 13(1), 9600 (2023).
- 36. . Transforming growth factor beta (TGF-beta) isoforms in wound healing and fibrosis. Wound Repair Regen. 24(2), 215–222 (2016).
- 37. The initiation of embryonic-like collagen fibrillogenesis by adult human tendon fibroblasts when cultured under tension. Biomaterials 31(18), 4889–4897 (2010).
- 38. . Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433(7027), 760–764 (2005).
- 39. Fetal tendon wound size modulates wound gene expression and subsequent wound phenotype. Wound Repair Regen. 18(5), 543–549 (2010).
- 40. . Interrelation of immunity and tissue repair or regeneration. Semin. Cell Dev. Biol. 20(5), 517–527 (2009).
- 41. . Spatiotemporal protein distribution of TGF-betas, their receptors, and extracellular matrix molecules during embryonic tendon development. Dev. Dyn. 237(5), 1477–1489 (2008).
- 42. . Recruitment and maintenance of tendon progenitors by TGFbeta signaling are essential for tendon formation. Development 136(8), 1351–1361 (2009).
- 43. . TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses. J. Dent. Res. 81(10), 688–694 (2002).
- 44. . Transforming growth factor-beta(1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars. Eur. Cytokine Netw. 11(2), 233–239 (2000).
- 45. Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization. Am. J. Pathol. 163(6), 2459–2476 (2003).
- 46. . Identification of differentially regulated genes in fetal wounds during regenerative repair. Wound Repair Regen. 16(3), 450–459 (2008).
- 47. . Evaluating the cardiovascular safety of nonsteroidal anti-inflammatory drugs. Circulation 135(21), 2062–2072 (2017).
- 48. . The effects of common anti-inflammatory drugs on the healing rat patellar tendon. Am. J. Sports Med. 35(8), 1326–1333 (2007).
- 49. The detrimental effects of systemic ibuprofen delivery on tendon healing are time-dependent. Clin. Orthop. Relat. Res. 472(8), 2433–2439 (2014).
- 50. . Ibuprofen inhibition of tendon cell migration and down-regulation of paxillin expression. J. Orthop. Res. 24(3), 551–558 (2006).
- 51. . Effects of celecoxib on migration, proliferation and collagen expression of tendon cells. Connect. Tissue Res. 48(1), 46–51 (2007).
- 52. . Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast. Reconstr. Surg. 105(1), 148–155 (2000).
- 53. . Tendon healing in vivo and in vitro: neutralizing antibody to TGF-beta improves range of motion after flexor tendon repair. Orthopedics 33(11), 809 (2010).
- 54. . Effectiveness of microRNA in down-regulation of TGF-beta gene expression in digital flexor tendons of chickens: in vitro and in vivo study. J. Hand Surg. 34(10), 1777–1784; e1771 (2009).
- 55. Tendon healing in vitro: adeno-associated virus-2 effectively transduces intrasynovial tenocytes with persistent expression of the transgene, but other serotypes do not. Plast. Reconstr. Surg. 119(1), 227–234 (2007).
- 56. . Adeno-associated virus-2-mediated TGF-beta1 microRNA transfection inhibits adhesion formation after digital flexor tendon injury. Gene Ther. 23(2), 167–175 (2016).
- 57. . Nanoparticle-mediated delivery of TGF-beta1 miRNA plasmid for preventing flexor tendon adhesion formation. Biomaterials 34(33), 8269–8278 (2013).
- 58. . The role of transforming growth factor beta isoforms in tendon-to-bone healing. Connect. Tissue Res. 52(2), 87–98 (2011).
- 59. Gene expression analysis of the pleiotropic effects of TGF-beta1 in an in vitro model of flexor tendon healing. PLoS ONE 7(12), e51411 (2012).
- 60. . Effect of TGF-beta inducible early gene deficiency on flexor tendon healing. J. Orthop. Res. 24(3), 569–575 (2006).
- 61. . Metalloproteinases and their inhibitors: regulators of wound healing. Int. J. Biochem. Cell Biol. 40(6-7), 1334–1347 (2008).
- 62. . TGF-beta1 suppresses plasmin and MMP activity in flexor tendon cells via PAI-1: implications for scarless flexor tendon repair. J. Cell. Physiol. 230(2), 318–326 (2015).
- 63. . PAI-1 in tissue fibrosis. J. Cell. Physiol. 227(2), 493–507 (2012).
- 64. Serpine1 knockdown enhances MMP activity after flexor tendon injury in mice: implications for adhesions therapy. Sci. Rep. 8(1), 5810 (2018).
- 65. Evaluation of the effects of transforming growth factor-beta 3 (TGF-beta3) loaded nanoparticles on healing in a rat Achilles tendon injury model. Am. J. Sports Med. 50(4), 1066–1077 (2022).
- 66. . Sustained delivery of transforming growth factor beta three enhances tendon-to-bone healing in a rat model. J. Orthop. Res. 29(7), 1099–1105 (2011).
- 67. . Repair of rotator cuff tendon defects in aged rats using a growth factor injectable gel scaffold. Arthroscopy 36(3), 629–637 (2020).
- 68. TGF-beta3 loaded electrospun polycaprolacton fibre scaffolds for rotator cuff tear repair: an in vivo study in rats. Int. J. Mol. Sci. 21(3), 1046 (2020).
- 69. Calcium–phosphate matrix with or without TGF-beta3 improves tendon-bone healing after rotator cuff repair. Am. J. Sports Med. 39(4), 811–819 (2011).
- 70. . Molecular engineering of the TGF-beta signaling pathway. J. Mol. Biol. 431(15), 2644–2654 (2019).
- 71. . Post-translational regulation of TGF-beta receptor and Smad signaling. FEBS Lett. 586(14), 1871–1884 (2012).
- 72. . Targeting TGF-beta signal transduction for fibrosis and cancer therapy. Mol. Cancer 21(1), 104 (2022).
- 73. . TGF-beta signaling from receptors to Smads. Cold Spring Harb. Perspect. Biol. 8(9), a022061 (2016).
- 74. . TGF-beta and the TGF-beta family: context-dependent roles in cell and tissue physiology. Cold Spring Harb. Perspect. Biol. 8(5), a021873 (2016).
- 75. TGF-beta: a master immune regulator. Expert Opin. Ther. Targets 24(5), 427–438 (2020).
- 76. . Rebalancing SMAD7/SMAD3 signaling reduces adhesion formation during flexor tendon healing. J. Microbiol. Biotechnol. 33(3), 339–347 (2023).
- 77. Impact of Smad3 loss of function on scarring and adhesion formation during tendon healing. J. Orthop. Res. 29(5), 684–693 (2011).
- 78. . Gait analysis combined with the expression of TGF-beta1, TGF-beta3 and CREB during Achilles tendon healing in rat. Chin. J. Traumatol. 24(6), 360–367 (2021).
- 79. . Effect of transforming growth factor-beta3 on the expression of Smad3 and Smad7 in tenocytes. Mol. Med. Rep. 13(4), 3567–3573 (2016).
- 80. Effects and mechanism of particulate matter on tendon healing based on integrated analysis of DNA methylation and RNA sequencing data in a rat model. Int. J. Mol. Sci. 23(15), 8170 (2022).
- 81. . Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretion. J. Biol. Chem. 281(40), 29479–29490 (2006).
- 82. Polydeoxyribonucleotide ameliorates inflammation and apoptosis in Achilles tendon-injury rats. Int. Neurourol. J. 24(Suppl. 2), 79–87 (2020).
- 83. Up-regulation of CREB-1 regulates tendon adhesion in the injury tendon healing through the CREB-1/TGF-beta3 signaling pathway. BMC Musculoskelet. Disord. 24(1), 325 (2023).
- 84. TGF-beta3 and IGF-1 synergy ameliorates nucleus pulposus mesenchymal stem cell differentiation towards the nucleus pulposus cell type through MAPK/ERK signaling. Growth Factors 33(5-6), 326–336 (2015).
- 85. . Regulatory roles of MAPK phosphatases in cancer. Immune Netw. 16(2), 85–98 (2016).
- 86. . Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23(16), 2838–2849 (2004).
- 87. Mangiferin protect myocardial insults through modulation of MAPK/TGF-beta pathways. Eur. J. Pharmacol. 776, 34–43 (2016).
- 88. Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway. Cell Prolif. 52(4), e12650 (2019).
- 89. The effect of adipose-derived stem cell sheets and CTGF on early flexor tendon healing in a canine model. Sci. Rep. 8(1), 11078 (2018).
- 90. . TGF-beta3 regulates adhesion formation through the JNK/c-Jun pathway during flexor tendon healing. BMC Musculoskelet. Disord. 22(1), 843 (2021).
- 91. NF-kappaB activation persists into the remodeling phase of tendon healing and promotes myofibroblast survival. Sci. Signal. 13(658), eabb7209 (2020).
- 92. . TGF-beta1, TGF-beta3, and PGE(2) regulate contraction of human patellar tendon fibroblasts. Biomech. Model. Mechanobiol. 2(4), 239–245 (2004).
- 93. . Expression of transforming growth factor beta isoforms and their roles in tendon healing. Wound Repair Regen. 16(3), 399–407 (2008).
- 94. . TGF-beta superfamily signaling in muscle and tendon adaptation to resistance exercise. Exerc. Sport Sci. Rev. 43(2), 93–99 (2015).
- 95. Inhibition of overactive TGF-beta attenuates progression of heterotopic ossification in mice. Nat. Commun. 9(1), 551 (2018).